1. Home
  2. VCYT vs SEZL Comparison

VCYT vs SEZL Comparison

Compare VCYT & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • SEZL
  • Stock Information
  • Founded
  • VCYT 2006
  • SEZL 2016
  • Country
  • VCYT United States
  • SEZL United States
  • Employees
  • VCYT N/A
  • SEZL N/A
  • Industry
  • VCYT Medical Specialities
  • SEZL Diversified Financial Services
  • Sector
  • VCYT Health Care
  • SEZL Finance
  • Exchange
  • VCYT Nasdaq
  • SEZL Nasdaq
  • Market Cap
  • VCYT 2.8B
  • SEZL 3.0B
  • IPO Year
  • VCYT 2013
  • SEZL N/A
  • Fundamental
  • Price
  • VCYT $36.80
  • SEZL $77.37
  • Analyst Decision
  • VCYT Buy
  • SEZL Buy
  • Analyst Count
  • VCYT 10
  • SEZL 4
  • Target Price
  • VCYT $40.40
  • SEZL $113.75
  • AVG Volume (30 Days)
  • VCYT 788.0K
  • SEZL 753.8K
  • Earning Date
  • VCYT 11-04-2025
  • SEZL 11-05-2025
  • Dividend Yield
  • VCYT N/A
  • SEZL N/A
  • EPS Growth
  • VCYT N/A
  • SEZL 146.46
  • EPS
  • VCYT 0.34
  • SEZL 2.93
  • Revenue
  • VCYT $479,129,000.00
  • SEZL $371,794,890.00
  • Revenue This Year
  • VCYT $14.48
  • SEZL $65.77
  • Revenue Next Year
  • VCYT $9.79
  • SEZL $27.29
  • P/E Ratio
  • VCYT $109.69
  • SEZL $26.22
  • Revenue Growth
  • VCYT 19.91
  • SEZL 92.95
  • 52 Week Low
  • VCYT $22.61
  • SEZL $24.86
  • 52 Week High
  • VCYT $47.32
  • SEZL $186.74
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 62.00
  • SEZL 42.07
  • Support Level
  • VCYT $34.38
  • SEZL $70.63
  • Resistance Level
  • VCYT $37.07
  • SEZL $76.64
  • Average True Range (ATR)
  • VCYT 1.23
  • SEZL 4.58
  • MACD
  • VCYT -0.06
  • SEZL 0.51
  • Stochastic Oscillator
  • VCYT 90.96
  • SEZL 39.65

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About SEZL Sezzle Inc.

Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.

Share on Social Networks: